Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression

被引:127
作者
Kasper, LH
Boussouar, F
Boyd, K
Xu, W
Biesen, M
Rehg, J
Baudino, TA
Cleveland, JL
Brindle, PK
机构
[1] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
关键词
CBP; CH1; HIF; hypoxia; p300;
D O I
10.1038/sj.emboj.7600846
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The C-terminal activation domain (C-TAD) of the hypoxia-inducible transcription factors HIF-1 alpha and HIF-2 alpha binds the CH1 domains of the related transcriptional coactivators CREB-binding protein (CBP) and p300, an oxygen-regulated interaction thought to be highly essential for hypoxia-responsive transcription. The role of the CH1 domain in vivo is unknown, however. We created mutant mice bearing deletions in the CH1 domains (Delta CH1) of CBP and p300 that abrogate their interactions with the C-TAD, revealing that the CH1 domains of CBP and p300 are genetically non-redundant and indispensable for C-TAD transactivation function. Surprisingly, the CH1 domain was only required for an average of similar to 35-50% of global HIF-1-responsive gene expression, whereas another HIF transactivation mechanism that is sensitive to the histone deacetylase inhibitor trichostatin A (TSA(S)) accounts for similar to 70%. Both pathways are required for greater than 90% of the response for some target genes. Our findings suggest that a novel functional interaction between the protein acetylases CBP and p300, and deacetylases, is essential for nearly all HIF-responsive transcription.
引用
收藏
页码:3846 / 3858
页数:13
相关论文
共 43 条
[31]   Genetic heterogeneity in Rubinstein-Taybi syndrome:: Mutations in both the CBP and EP300 genes cause disease [J].
Roelfsema, JH ;
White, SJ ;
Ariyürek, Y ;
Bartholdi, D ;
Niedrist, D ;
Papadia, F ;
Bacino, CA ;
den Dunnen, JT ;
van Ommen, GJB ;
Breuning, MH ;
Hennekam, RC ;
Peters, DJM .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :572-580
[32]   Role of CBP in regulating HIF-1-mediated activation of transcription [J].
Ruas, JL ;
Poellinger, L ;
Pereira, T .
JOURNAL OF CELL SCIENCE, 2005, 118 (02) :301-311
[33]   Physiology meets biophysics:: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP [J].
Semenza, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11570-11572
[34]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732
[35]   Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300 [J].
Simone, C ;
Stiegler, P ;
Forcales, SV ;
Bagella, L ;
De Luca, A ;
Sartorelli, V ;
Giordano, A ;
Puri, AL .
ONCOGENE, 2004, 23 (12) :2177-2187
[36]   Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein [J].
Tanaka, Y ;
Naruse, I ;
Hongo, T ;
Xu, MJ ;
Nakahata, T ;
Maekawa, T ;
Ishii, S .
MECHANISMS OF DEVELOPMENT, 2000, 95 (1-2) :133-145
[37]  
Warner DR, 2002, IN VITRO CELL DEV-AN, V38, P48, DOI 10.1290/1071-2690(2002)038<0048:EOTNCC>2.0.CO
[38]  
2
[39]   Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage [J].
Wood, MA ;
Kaplan, MP ;
Park, A ;
Blanchard, EJ ;
Oliveira, AMM ;
Lombardi, TL ;
Abel, T .
LEARNING & MEMORY, 2005, 12 (02) :111-119
[40]   c-Jun and the dominant-negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1 [J].
Wu, YZ ;
Zhang, XP ;
Zehner, ZE .
ONCOGENE, 2003, 22 (55) :8891-8901